Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer

PURPOSE: Pathological complete response (pCR) is the goal of neoadjuvant chemotherapy (NAC) for the HER2-positive and triple-negative subtypes of breast cancer and is related to survival benefit; however, luminal breast cancer is not sensitive to NAC, and the size of tumor shrinkage is a more meanin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Shuai, Wang, Wenjie, Zhu, Bifa, Pan, Xixi, Wu, Xiaoyan, Tao, Weiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489938/
https://www.ncbi.nlm.nih.gov/pubmed/32982426
http://dx.doi.org/10.2147/CMAR.S270687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489938/
https://www.ncbi.nlm.nih.gov/pubmed/32982426
http://dx.doi.org/10.2147/CMAR.S270687

Ejemplares similares